February’s DTB
The February 2010 issue of Drug and Therapeutics Bulletin (DTB) [volume 48,
number 2] contains an editorial and three articles. The editorial discusses
concerns arising from the European Commission’s proposals for changing the
arrangements for licensing drugs and monitoring patient safety. The first
article is a review of the management of community-associated MRSA. The
second article discusses the use of ▼Pregabalin for generalised anxiety
disorder. The third article highlights changes to the reporting of HbA1c
levels. A podcast outlining what is in the February issue is also available
via our website www.dtb.bmj.com.